Study of a special filter for septic shock patients
Part of Infections clinical trials.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have septic shock, meaning your blood pressure is low despite fluids and you need medication to keep it up.
- You are on a type of kidney replacement therapy (CVVH) with the Oxiris filter for at least 24 hours.
- You are over 18 years old.
- You are not pregnant.
- You do not have any condition that makes citrate (used to prevent clotting) unsafe for you.
- You are not expected to pass away within 24 hours from other serious illnesses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special type of dialysis filter (oXiris) helps reduce blood clotting problems in patients with septic shock and kidney failure. It may offer a better option for those needing kidney support in the ICU.
This study tests a special blood filter (Oxiris) to see if it helps clean the blood in people with septic shock. If you are receiving blood purification therapy, this filter might help your body recover better.
This trial tests a special blood filter (hemoadsorption) for people in septic shock (a severe infection causing very low blood pressure). It aims to see if the filter helps remove harmful substances from the blood and improve recovery.
This trial tests a special blood-filtering device (OXiris) for people with severe abdominal infections that cause septic shock and kidney damage. It aims to see if this treatment can help control the infection and improve recovery.
This trial tests whether a blood-filtering device can help people with septic shock by removing harmful substances from the blood. It is for adults who have been diagnosed with septic shock within the last 24 hours.
This trial tests whether a blood filtering treatment called hemoadsorption can help protect blood vessels in people with septic shock. It may be an option for patients who are already on strong blood pressure medications and steroids.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.